Market Overview

UPDATE: BMO Capital Markets Reiterates Outperform Rating, Raises PT on Cigna Corporation

Share:
Related CI
Managed Care Stocks Might Be The Best Defense Against Market Volatility
Virginia Cancer Institute and Cigna Collaborate to Improve Care for People Undergoing Cancer Treatment
Amerisafe Maintains Niche Position in High-Hazard Insurance (Zacks)

In a report published Monday, BMO Capital Markets reiterated its Outperform rating on Cigna Corporation (NYSE: CI), and raised its price target from $60.00 to $65.00.

BMO Capital noted, “During the Investor Day this year, Cigna outlined its strategy for growth thus far and in the future. International and commercial Healthcare are current and future bright spots, promising ASO membership and above peer expansion. New this year was investor breakout sessions, which allowed attendees to participate in smaller discussion groups with management. Through these sessions, commercial healthcare continues to play an outsized role when it comes to the valuation of CI shares. As presentations marched on, investor concerns continued to analyze the shifting landscape for 2014. Questions around the industry tax, star ratings and exchange dynamics showed that while we are closer to 2014 we still have a lot to learn. We are raising our price target to $65 to reflect the strengthening fundamentals.”

Cigna Corporation closed on Friday at $50.47.

Latest Ratings for CI

DateFirmActionFromTo
Jul 2015BarclaysMaintainsEqual-weight
Jul 2015Sterne AgeeUpgradesNeutralBuy
Jul 2015SusquehannaMaintainsPositive

View More Analyst Ratings for CI
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Price Target Analyst Ratings

 

Related Articles (CI)

View Comments and Join the Discussion!

Get Benzinga's Newsletters